February 8, 2018 / 12:01 PM / 4 months ago

BRIEF-Alexion Pharma Q4 GAAP Earnings Per Share $0.13

Feb 8 (Reuters) - Alexion Pharmaceuticals Inc:

* ALEXION REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS AND PROVIDES FINANCIAL GUIDANCE FOR 2018

* Q4 NON-GAAP EARNINGS PER SHARE $1.48

* SEES 2018 GAAP EARNINGS PER SHARE‍​ $4.35 TO $4.75

* SEES 2018 NON-GAAP EARNINGS PER SHARE $6.60 TO $6.80

* ALEXION PHARMACEUTICALS - GAAP INCOME TAX EXPENSE FOR QUARTER INCLUDES $45.8 MILLION CHARGE RELATED TO U.S. TAX REFORM

* SEES 2018 GAAP OPERATING MARGIN 31% TO 34%

* SEES 2018 NON-GAAP OPERATING MARGIN 48% TO 49%

* ALEXION SAYS 2018 GUIDANCE ASSUMES GAAP EFFECTIVE TAX RATE OF 15 - 17 PERCENT (INCLUSIVE OF CO’S PROVISIONAL ASSESSMENT OF U.S. TAX REFORM IMPACT) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below